Journals / Molecular Imaging and Radionuclide Therapy / 2020 / Cilt: 29 - Sayı: 1

Metabolic Characteristics and Diagnostic Contribution of 18F-FDG PET/CT in Gastric Carcinomas

Mide Kanserinin Metabolik Özellikleri ve 18F-FDG PET/BT’nin Tanısal Katkısı

Pages
25–32
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Primary tumor SUVmax was found statistically higher in regional lymph node (RLN) positive patients than in RLN negative patients in AC and SRCC groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to evaluate 18F-fluoro-2-deoxy-glucose (FDG) uptake patterns in primary tumors and metastatic lesions, and also to assess the diagnostic contribution of positron emission tomography/computed tomography (PET/CT) in the initial staging of gastric cancer (GC).Methods: The total number of 341 patients with GC were included in this study.
📊
Key Findings & Data:All 18F-FDG PET/CT imagings were performed for initial staging.
💡
Conclusion & Impact:Primary tumor SUVmax was found statistically higher in regional lymph node (RLN) positive patients than in RLN negative patients in AC and SRCC groups (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of this study was to evaluate 18F-fluoro-2-deoxy-glucose (FDG) uptake patterns in primary tumors and metastatic lesions, and also to assess the diagnostic contribution of positron emission tomography/computed tomography (PET/CT) in the initial staging of gastric cancer (GC).Methods: The total number of 341 patients with GC were included in this study. All 18F-FDG PET/CT imagings were performed for initial staging. The maximum standardized uptake value (SUVmax) of primary tumor, obtained from 18F-FDG PET/CT imaging was compared between subtypes of GC.Results: Mean SUVmax of 339 patients’ primary tumor was 12.9±8.6. The highest mean SUVmax was detected in patients with medullary subtype GC (17.8±9.9) while the lowest mean SUVmax (9.7±7.6) was seen in signet ring cell carcinoma (SRCC). The primary mean SUVmax was found statistically higher in adenocarcinoma (AC) group than SRCC group (p3 cm) in patients with AC (p=0.03). Primary tumor SUVmax was found statistically higher in regional lymph node (RLN) positive patients than in RLN negative patients in AC and SRCC groups (p

Özet

Amaç: Bu çalışmanın amacı primer tümörlerde ve metastatik lezyonlarda 18F-floro-2-deoksi-glukoz (18F-FDG) tutulum paternlerini değerlendirmek ve ayrıca mide kanserinin (MK) evrelemesinde pozitron emisyon tomografi/bilgisayarlı tomografi’nin (PET/BT) tanısal katkısını değerlendirmektir.Yöntem: Çalışmaya toplam 341 MK hastası dahil edildi. Primer evreleme 18F-FDG PET/BT görüntüleme ile yapıldı. 18F-FDG PET/BT görüntülemeden elde edilen primer tümöre ait maksimum standart tutulum (SUVmax) MK alt tipleri arasında karşılaştırıldı.Bulgular: Üç yüz otuz dokuz hastaya ait primer tümörün ortalama SUVmax değeri 12,9±8,6 idi. En yüksek ortalama SUVmax, medüller alt tip MK’li hastalarda (17,8±9,9), en düşük ortalama SUVmax (9,7±7,6), taşlı yüzük hücreli mide kanserinde (TYHMK) görüldü. Ortalama SUVmax, adenokarsinom (AK) grubunda TYHMK grubundan istatistiksel olarak daha yüksek bulundu (p3 cm) ile istatistiksel olarak anlamlı derecede ilişkili bulundu (p=0,03). Primer tümör SUVmax, bölgesel lenf nodu (RLN) pozitif olan hastalarda AK ve TYHMK gruplarındaki RLN negatiflerden anlamlı olarak yüksek bulundu (p

🔖

Cite This Article

DURSUN, N., ARSLAN, E., ÇERMİK, T. F., AKSOY, T., GÜNDOĞAN, C., ŞEN, Ç., TATAR, S. Y. (2022). Metabolic Characteristics and Diagnostic Contribution of 18F-FDG PET/CT in Gastric Carcinomas. Molecular Imaging and Radionuclide Therapy, Cilt: 29 - Sayı: 1, 25–32. https://ajindex.com/articles/581569

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Luo G, Zhang Y, Guo P, Wang L, Huang Y, Li K. Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis. Int J Cancer 2017;141:1333-1344.
  2. Schumacher SE, Shim BY, Corso G, Ryu MH, Kang YK, Roviello F, Saksena G, Peng S, Shivdasani RA, Bass AJ, Beroukhim R. Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients. PLoS One 2017;12:e0176045. GE4GAC group, Soares FA, Coimbra FJF, Pelosof AG, Freitas HC, Begnami MD, Costa WL, Fannelli MF, Mello CAL, Amorim MG, Pizzi MP, Caramelo L, Ferreira EN, Barros BDF, Torrezan GT, Ramalho R, Carraro DM, Chulam T, Carvalho FS, Carvalho DD, Krepischi ACV, Santos ET, Coelho LGV, Sant’Ana RO, Burbano RR, Assumpção P, Setúbal JC, Thomas AM, Chinen LTD, Braun AC, Alves V, Cassinela EK, Oliveira GP, Landemberger MC, Valieris R, Drummond R, Silva IG, Cézar R, Calsavara VF, Nóbrega CR, Bobrovnitchaia IG, Bartelli TF, Baladão GPB, Pereira ACC, Gatti CM, Abrantes LLS, Martins VR, Nunes DN, Curado MP, Neto ED. Genomics and epidemiology for gastric adenocarcinomas. Applied Cancer Research, 2017;37:1-9.
  3. Shah MA, Strong VE, Boughey JC. A new approach for advanced gastric cancer: Using PET scans as a biomarker of preoperative chemotherapy efficacy. Bull Am Coll Surg 2017;102:46-48.
  4. Wu Z, Zhao J, Gao P, Song Y, Sun J, Chen X, Ma B, Wang Z. Prognostic value of pretreatment standardized uptake value of F-18- fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis. BMC Cancer 2017;17:275. Groheux D, Cochet A, Humbert O, Alberini JL, Hindié E, Mankoff D. 18F-FDG PET/CT for staging and restaging of breast cancer. J Nucl Med 2016;57:17-26.
  5. Cerfolio RJ, Bryant AS. Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg 2006;82:391-395.
  6. Lopez Guerra JL, Gladish G, Komaki R, Gomez D, Zhuang Y, Liao Z. Large decreases in standardized uptake values after definitive radiation are associated with better survival of patients with locally advanced nonsmall cell lung cancer. J Nucl Med 2012;53:225-233.
  7. Filik M, Kir KM, Aksel B, Soyda Ç, Özkan E, Küçük ÖN, İbiş E, Akgül H. The role of 18F-FDG PET/CT in the primary staging of gastric cancer. Mol Imaging Radionucl Ther 2015;24:15-20.
  8. Kaneko Y, Murray WK, Link E, Hicks RJ, Duong C. Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer. J Nucl Med 2015;56:523-529. 11. Amin MB, Edge SB, Greene FL, Brier